Radiation pneumonitis following combined modality therapy for lung cancer: Analysis of prognostic factors

Journal of Clinical Oncology

Volumn 13, Issue 10, 1995, Pages 2606-2612

  Roach III, Mack ^a   Gandara, David R ^b   Yuo, Hae Sook ^b   Swift, Patrick S ^b   Kroll, Stewart ^b   Shrieve, Dennis C ^b   Wara, William M ^b   Margolis, Larry ^b   Phillips, Theodore L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; CANCER GRADING; CLINICAL FEATURE; COUGHING; DYSPNEA; FEVER; HUMAN; IRRADIATION; LEUKOCYTOSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION PNEUMONIA; RISK BENEFIT ANALYSIS; TACHYCARDIA; THORAX PAIN;

EID: 0029116899     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1995.13.10.2606     Document Type: Article

References (48)

1. Strauss GM, Langer MP, Elias AD, et al: Multimodality treatment of stage IIIA non-small-cell lung carcinoma: A critical review of the literature and strategies for future research. J Clin Oncol 10:829-838, 1992
2. Warde P, Payne D: Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 10:890-895, 1992
3. Wara WM, Phillips TL, Margolis LW, et al: Radiation pneumonitis: A new approach to the derivation of time-dose factors. Cancer 32:547-552, 1973
4. Phillips TL, Fu KK: Quantification of combined radiation therapy and chemotherapy effects on critical normal tissues. Cancer 37:1186-1200, 1976
5. von der Masse H, Overgaard J, Vaeth M: Effect of cancer chemotherapeutic drugs on radiation-induced lung damage in mice. Radiother Oncol 5:245-257, 1986
6. Sherman DM, Carabell SC, Belli JA, et al: The effect of dose rate and Adriamycin on the tolerance of thoracic radiation in mice. Int J Radiat Oncol Biol Phys 8:45-51, 1982
7. Redpath JL, David RM, Colman M: The effect of Adriamycin on radiation damage to mouse lung and skin. Int J Radiat Oncol Biol Phys 4:229-232, 1978
8. Ginsberg SJ, Comis RL: The pulmonary toxicity of antineoplastic agents. Semin Oncol 9:34-51, 1982
9. Tanabe M, Godat D, Kallman RF: Effects of fractionated schedules of irradiation combined with cis-diamminedichloroplatinum II on the SCCVII/ST tumor and normal tissues of the C3H/ KM mouse. Int J Radiat Oncol Biol Phys 13:1523-1532, 1987
10. Roach M, Phillips TL: Pulmonary toxicity and combined modality therapy, in John MJ, Flam MS, Legha SS, et al (eds): Chemoradiation: An Integrated Approach to Cancer Treatment. Malvern, PA, Lea & Febiger. 1993, pp 444-459
11. Rubin P, Cassert GW: Clinical Radiation Pathology, vol 1. Philadelphia PA, Saunders, 1968, pp 423-470
12. McDonald S, Rubin P, Massilta P: Response of normal lung to irradiation. Front Radiat Ther Oncol 23:255-276, 1989
13. Travis EL, Terry NHA: Cell depletion and initial and chronic responses in normal tissues. Front Radiat Ther Oncol 23:41-59, 1989
14. Roach M, Brophy N, Cox R, et al: Prognostic factors for patients relapsing after radiotherapy for early stage Hodgkin's disease. J Clin Oncol 8:623-629, 1990
15. Thames HD, Peters LJ, Ang KK: Time-dose considerations for normal tissue tolerance. Front Radiat Ther Oncol 23:113-130, 1989
16. McCullagh P, Nelder JA: Generalized Linear Models (ed 2). London, England, Chapman & Hall, 1989, pp 124-128
17. Einhorn L, Krause M, Hornback N, et al: Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell lung cancer. Cancer 37:2414-2416, 1976
18. Verschoore J, Lagrange J, Boublil J, et al: Pulmonary toxicity of a combination of low-dose doxorubicin and irradiation for inoperable lung cancer. Radiother Oncol 9:281-288, 1987
19. Perry MC, Eaton WL, Propert KJ, et al: Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med 316:912-918, 1987
20. Dillman RO, Seagren SL, Propert KJ, et al: A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323:940-945, 1990
21. Gandara DR, Valone F, Perez EA, et al: Alternating radiotherapy and high dose cisplatin chemotherapy in stage IIIB non-small cell lung cancer: Results of a phase I-II study. Int J Radial Oncol Biol Phys 20:1047-1052, 1991
22. Turrisi AT, Glover DJ, Mason B: A preliminary report: Concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer. Int J Radiat Oncol Biol Phys 15:183-187, 1988
23. Choi NC, Prophert K, Carey R, et al: Accelerated radiotherapy followed by chemotherapy for locally recurrent small-cell carcinoma of the lung. A phase II Study of Cancer and Leukemia Group B. Int J Radiat Oncol Biol Phys 13:263-266, 1987
24. Murray N, et al: Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. J Clin Oncol 11:336-344, 1993
25. Morton RF, et al: Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. Ann Intern Med 115:681-686, 1991
26. Kies MS, et al: Multimodal therapy for limited small-cell lung cancer: A randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders: And with wide-field versus reduced-field radiation in partial responders: A Southwest Oncology Group study. J Clin Oncol 5:592-600, 1987
27. Bunn PA, et al: Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. Ann Intern Med 106:655-662, 1987
28. Jett JR, et al: Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: A randomized trial of the North Central Cancer Treatment Group. J Clin Oncol 8:33-39, 1990
29. Schaake-Koning C, et al: Radiotherapy combined with low-dose cis-diammine dichloroplatinum (II) (CDDP) in inoperable non-metastatic non-small cell lung cancer (NSCLC): A randomized three arm phase II study of the EORTC Lung Cancer and Radiotherapy Cooperative Groups. Int J Radiat Oncol Biol Phys 19:967-972, 1990
30. Soresi E, Clerici M, Grilli R, et al: A randomized clinical trial comparing radiation therapy v radiation therapy plus cis-dichlorodiammine platinum (II) in the treatment of locally advanced non-small cell lung cancer. Semin Oncol 15:20-25, 1988
31. Collins C, Higano CS, Livingston RB, et al: Cyclophosphamide, vincristine, cisplatin, VP-16, and radiation therapy in extensive small-cell ling cancer. Cancer Chemother Pharmacol 24:128-132, 1989
32. Nagy-Mignotte H, Bolla M, Wuyam B, et al: Sequential combination of 5-fluorouracil, cis-platinum and irradiation in unresectablc non-small cell lung cancer. Radiother Oncol 15:333-339, 1989
33. Van Harskamp G, Boven E, Vermorken JB, et al: Phase II trial of combined radiotherapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 13:1735-1738, 1987
34. Friess GG, Baikadi M, Harvey WH: Simultaneous cisplatin and etoposide with radiation therapy in locoregional non-small cell lung cancer. Final results of a pilot trial, in Gralla RJ, Einhorn LH (eds): Small Cell Lung Cancer and Non-Small Cell Lung Cancer. Royal Society of Medicine Services International Congress and Symposium series no. 150. London, United Kingdom, Royal Society of Medicine Services, 1989, pp 121-126
35. Mirimanoff RO, Alberto P, Leyvraz S, ct al: Alternating accelerated radiotherapy (ART) and chemotherapy (CT) for inoperable, non-metastatic, non-small cell lung carcinoma (NSCLC): A phase II collaborative study. Third International Conference on the Interaction of Radiation Therapy and Systemic Therapy. Monterey, CA, March 12, 1990 (abstr 2-10)
36. Coy P, Hodson I, Payne DG, et al: The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a Canadian multicenter randomized trial. Int J Radiat Oncol Biol Phys 14:219-226, 1988
37. Shank B, Natale RB, Hilaris BS, et al: Treatment of small cell carcinoma of lung with combined high dose mediastinal irradiation, whole brain prophylaxis and chemotherapy. Int J Radiat Oncol Biol Phys 7:469-475, 1981
38. McCracken D, Janaki LM, Crowley JJ, et al: Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: A Southwest Oncology Group study. J Clin Oncol 8:892-898, 1990
39. Mornex F, Trillet V, Chauvin F, et al: Hyperfractionated radiotherapy alternating with multidrug chemotherapy in the treatment of limited small cell lung cancer (SCLC). Int J Radiat Oncol Biol Phys 19:23-30, 1990
40. Shaw EG, McGinnis WL, Jett JR, et al: Pilot study of accelerated hyperfractionated thoracic radiation therapy plus concomitant etoposide and cisplatin chemotherapy in patients with unresectable stage III non-small-cell carcinoma of the lung. J Natl Cancer Inst 85:321-323, 1993
41. Fowler JF: What next in fractionated radiotherapy? Br J Cancer 49:285-300, 1984 (suppl 6)
42. Hall EJ: Radiobiology for the Radiologist (ed 3). Philadelphia. PA, Lippincott, 1988
43. Choi NC, Kanarek DJ, Kazemi H: Physiologic changes in pulmonary function after thoracic radiotherapy for patients with lung cancer and role of regional pulmonary function studies in predicting postradiotherapy pulmonary function before radiotherapy. Cancer Treat Symp 2:119-130, 1985
44. Curran WJ, Moldofsky PJ, Solin LJ: Analysis of the influence of elective nodal irradiation on postirradiation pulmonary function. Cancer 65:2488-2493, 1990
45. Martel MK, Ten Haken R, Hazuka MB, et al: Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys 28:575-581, 1994
46. Brundage MD, Pater JL, Zee B: Assessing the reliability of two toxicity scales: Implications for interpreting toxicity data. J Natl Cancer Inst 85:1138-1148, 1993
47. Perez CA, Bauer M, Edelstein S, et al: Impact of tumor control on survival in carcinoma of the lung treated with irradiation. Int J Radiat Oncol Biol Phys 12:539-547, 1986
48. Medical Research Council Lung Cancer Working Group: Inoperable non-small-cell lung cancer (NSCLC): A Medical Research Council randomized trial of palliative radiotherapy with two fractions or ten fractions. Br J Cancer 63:265-270, 1991